#ARDS-003 entering Phase 2 #clinicaltrial in Q4-2020 for #CRS #Cytokine Relase Syndrome and or #ARDS Acute Respiratory Distress Syndrome with 10 years of data #Covid_19 👇💪 $tbp $tbpmf $mrk $pfe @TetraBioPharma $gsk $nvs @drsanjaygupta @ScottGottliebMD emergency use Q1 - 2021?? https://t.co/U2Rw9FkeOW